Publication | Closed Access
Amelioration of brain pathology and behavioral dysfunction in mice with lupus following treatment with a tolerogenic peptide
38
Citations
36
References
2009
Year
Treatment with hCDR1 ameliorated CNS pathology and improved the tested cognitive and mood-related behavior of the mice with lupus. Thus, hCDR1 is a novel candidate for the treatment of CNS lupus.
| Year | Citations | |
|---|---|---|
Page 1
Page 1